OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) CEO Aaron Green acquired 18,702 shares of the stock in a transaction on Monday, June 15th. The stock was bought at an average price of $0.54 per share, with a total value of $10,099.08. Following the transaction, the chief executive officer directly owned 1,859,725 shares of the company’s stock, valued at approximately $1,004,251.50. The trade was a 1.02% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Aaron Green also recently made the following trade(s):
- On Friday, June 12th, Aaron Green acquired 36,920 shares of OneMedNet stock. The shares were bought at an average cost of $0.56 per share, with a total value of $20,675.20.
OneMedNet Stock Performance
Shares of OneMedNet stock opened at $0.56 on Friday. OneMedNet Corporation has a 52-week low of $0.34 and a 52-week high of $4.22. The stock has a market capitalization of $30.44 million, a price-to-earnings ratio of -11.18 and a beta of 1.12. The company’s 50 day moving average price is $0.84 and its 200-day moving average price is $0.94.
Hedge Funds Weigh In On OneMedNet
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Exencial Wealth Advisors LLC lifted its stake in OneMedNet by 1.3% in the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after acquiring an additional 45,401 shares during the period. HRT Financial LP bought a new stake in OneMedNet in the fourth quarter valued at $32,000. Jane Street Group LLC purchased a new position in OneMedNet during the 4th quarter valued at $119,000. State Street Corp increased its position in OneMedNet by 41.5% during the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after purchasing an additional 34,200 shares during the period. Finally, Virtu Financial LLC bought a new position in OneMedNet in the 4th quarter worth $48,000. Institutional investors own 0.95% of the company’s stock.
Analysts Set New Price Targets
ONMD has been the topic of a number of analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen lowered shares of OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.
Check Out Our Latest Stock Analysis on ONMD
OneMedNet Company Profile
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
See Also
- Five stocks we like better than OneMedNet
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
